Sanofi’s vaccine finally approved by the European Medicines Agency

We stopped believing it would happen ! The Sanofi vaccine, developed in collaboration with the British GSK, has finally received the approval of the European Medicines Agency. Almost three years after the start of the Covid, and while the coronavirus has entered the endemic phase, it will be used as a reminder (or booster) regardless of the first vaccines received and without age limitation. It is the seventh to be approved on the Old Continent and the third booster after those of Pfizer-BioNTech and Moderna.

Influenza vaccine: Biogaran and GSK challenge the Sanofi-Viatris duopoly

Although it arrives very late on the market, it can claim to be the first booster available designed using a technology other than messenger RNA, known as recombinant proteins. This is a more traditional method, used in particular in the flu vaccine. The French lab hopes to convince the last recalcitrants, those who have not yet taken the step of vaccination out of mistrust of…